TABLE 7.

Improvement in individual symptoms.

Category		Test group	Control group	p-values
Dysfunction	Efficacy
N (Missing)		348 (8)	115 (2)
V3 (Day 4)	Cured	49 (13.8%)	17 (14.5%)	0.852
	Obvious effective	49 (13.8%)	17 (14.5%)	0.852
	Effective	158 (44.4%)	57 (48.7%)	0.438
V4 (Day 7)	Cured	172 (48.3%)	53 (45.3%)	0.533
	Obvious effective	173 (48.6%)	54 (46.2%)	0.607
	Effective	263 (73.9%)	93 (79.5%)	0.235
V5 (Day 10)	Cured	306 (86.0%)	96 (82.1%)	0.243
	Obvious effective	306 (86.0%)	96 (82.1%)	0.243
	Effective	327 (91.9%)	104 (88.9%)	0.194
Swelling
N (Missing)		292 (64)	96 (21)
V3 (Day 4)	Cured	89 (25.0%)	21 (17.9%)	0.105
	Obvious effective	89 (25.0%)	21 (17.9%)	0.105
	Effective	120 (33.7%)	35 (29.9%)	0.421
V4 (Day 7)	Cured	215 (60.4%)	54 (46.2%)	0.001
	Obvious effective	216 (60.7%)	55 (47.0%)	0.002
	Effective	239 (67.1%)	71 (60.7%)	0.101
V5 (Day 10)	Cured	269 (75.6%)	79 (67.5%)	0.005
	Obvious effective	269 (75.6%)	80 (68.4%)	0.013
	Effective	274 (77.0%)	84 (71.8%)	0.045
Ecchymosis
N (Missing)		163 (193)	57 (60)
V3 (Day 4)	Cured	32 (9.0%)	11 (9.4%)	0.956
	Obvious effective	32 (9.0%)	11 (9.4%)	0.956
	Effective	55 (15.4%)	18 (15.4%)	0.765
V4 (Day 7)	Cured	105 (29.5%)	35 (29.9%)	0.684
	Obvious effective	105 (29.5%)	36 (30.8%)	0.865
	Effective	132 (37.1%)	45 (38.5%)	0.739
V5 (Day 10)	Cured	138 (38.8%)	47 (40.2%)	0.488
	Obvious effective	138 (38.8%)	47 (40.2%)	0.488
	Effective	152 (42.7%)	53 (45.3%)	0.519

Statistics: Chi-square test or Fisher’s exact test was performed for curative effect analysis.